ISPOR’s Rob Abbott on why RWE moved to number two in the 2026-2027 HEOR Trends Report, and what wearables, data fragmentation, and HARPER+ mean for clinical platforms.
- AI Amplifies Capabilities But Also Risks: Learn The Legal Consequences Of AI In Clinical Research
- Is It Time To Replace RECIST — Or Just Add AI?
- Clinical Research Has System Sprawl Problem
- How Clinical Trial Sites Must Adapt To The Predictive Analytics Era
- Why Patients Drop Out And How To Stop Them
- Predictive Analytics Is Reshaping How Sponsors Run Clinical Trials
- AI In Clinical Trials: Real Impact, Real Limits, What's Next
- RWD Helps Researchers Include More Patients In Lymphoma Research
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
The Strategic Role Of KOLs In Rare Disease Drug Development
Engaging key Opinion Leaders (KOL) is crucial for accelerating rare disease research breakthroughs. However, identifying the right experts is challenging due to fragmented data and evolving expertise.
-
Accelerated Approval As The New "Norm" In Gene Therapy For Rare Diseases
Gene therapy has revolutionized treatment prospects for rare genetic disorders by enabling corrective or replacement strategies at the molecular level.
-
Transforming Field Rep Success
As the healthcare landscape evolves, maintaining accurate and timely information delivery becomes vital for building strong HCP relationships and improving patient outcomes.
-
Ensuring Patient-Centered Care In Oncology Trials
In oncology trials, safety and tolerability are a core focus. From centralized ECGs to patient-reported outcomes, utilize this guide for optimizing assessments of drug safety and quality of life.
-
Enhancing Competitive Intelligence In Pharma With Comprehensive Data Analysis
Discover a unified platform that turns complex pharma data into clear, strategic insights, empowering teams to outpace competitors with evidence-backed decisions from pipeline to launch.
-
Reinventing Prostate Cancer Diagnostics With An All-In-One Platform
Discover how a lean research team saved an estimated $100k and reached 95% data compliance by unifying their clinical workflow.
-
Open API Provides Better Access, Freedom To Build And Manage Studies
Discover how the integration of all manner of data platforms ranging from central labs to CTMS and beyond can help to overcome interoperability challenges in clinical research.
-
Connected Data For Mission-Critical, Time-Sensitive Moments In A Clinical Trial
Embrace the power of a unified eCOA and IRT platform to drive smarter decisions, ensure data accuracy, and boost efficiency across your studies.
-
How Sponsors Can Leverage New Technologies To Lower Trial Costs
This study introduces sponsors to an innovative, lean, and efficient approach to data management that integrates site-facing technologies to streamline trial operations.
-
The Power Of Site Enablement Platforms As An Insurance Policy
Delve into the pivotal role played by this Site Enablement Platform in upholding business continuity for clinical trials.
RECENT NEWSLETTERS
- 04.23.26 -- Smarter Trials Start Here: Data Quality, AI & Infrastructure Insights
- 04.16.26 -- 5 eTMF Questions, Agentic AI's Real Impact On Clinical Trials & More
- 04.09.26 -- AI In Clinical Trials: Recruitment, eCOA Risks & Data
- 04.04.26 -- Your March Briefing: The Best In Clinical Trial Tech
- 04.02.26 -- AI Is Reshaping Clinical Trials: Here's How to Keep Up